Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders

October 16, 2019 updated by: Christina Hunger, Heidelberg University

Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study

Goals of the study:

Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but lack explicit details about the clinical significance of the reductions they show in social anxiety symptoms. This project is funded by the German Association for Systemic Therapy, Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und Familientherapie: DGSF).

Study design:

The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders (SAD) in 32 patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Württemberg
      • Heidelberg, Baden-Württemberg, Germany, 69115
        • Institute of Medical Psychology, University Hospital Heidelberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Social Anxiety Disorder (SKID: ICD-Diagnosis: F40.1, Liebowitz Social Anxiety Scale > 30);
  • Agreement to participate in the study and to be randomized into the two treatment groups

Exclusion Criteria:

  • Acute drug or alcohol intoxication or dependency
  • Anorexia with BMI < 14
  • Psychotic disorder
  • Severe physical diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Systemic Therapy
Systemic Therapy deals with the experience in private social systems (e.g. couples. Family, friends) and organizational systems (e.g. work teams), their appraisals and the attitude of the members towards each other within the system. It is analyzed how these systems can lead to the development and maintenance of psychological disorders.
EXPERIMENTAL: Cognitive Behavioral Therapy
Cognitive Behavioral Therapy deals with individual behavior as well as individual attitude, thoughts, appraisals and beliefs, which can have an influence on the development and maintenance of psychological disorders.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Liebowitz Social Anxiety Scale (LSAS-SR)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Social Anxiety will be assessed using the Liebowitz Social Anxiety Scale (LSAS-SR) in its German version. The LSAS-SR is a brief 24-item self report instrument with 13 items relating to performance anxiety and 11 concerning social situations. Its purpose is to assess the range of social interaction and performance situations feared and the degree of avoidance by a patient in order to assist in the diagnosis of social anxiety disorder, 24 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Social Interaction Anxiety Scale (SIAS)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of social interaction anxiety, 20 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Social Phobia Scale (SPS)
Time Frame: Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomization
Measure of anxiety while being observed by others, 20 items, German version
Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Adjustment to Symptomatology Scale (ASS)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of adjustment to the symptomatology, 5 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Evaluation of Social Systems (EVOS)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of social relationships in different social systems, 10 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Experience in Social Systems (EXIS)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of the individual experience in different social systems, 24 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Beck Depression Inventory-II (BDI-II)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Severity of depressive symptoms "at that moment", specifically assessing the intensity of depression in psychiatric and normal populations, 21 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Brief Symptom Checklist (BSCL)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
The instrument provides an overview of a patient's symptoms and their intensity at a specific point in time, 53 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Inventory of Interpersonal Problems (IIP-32)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
The IIP-32 is a self-report instrument that identifies a person's most salient interpersonal difficulties. It is a short version of the Inventory of Interpersonal Problems, 32 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Dyadic Adjustment Scale (DAS-12)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of relationship adjustment, 12 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of University of Rhode Island Change Assessment (URICA-S, short version)
Time Frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of stages of change, 16 items, German version
Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Change of Burden Assessment Scale (BAS)
Time Frame: Baseline, 26th hour of therapy; 12 months after randomization
Measure of perceived burden in daily life among resource persons, 19 items, German version
Baseline, 26th hour of therapy; 12 months after randomization
Change of Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP),
Time Frame: 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Measure of the six dimensions of resource activation, problem actuation, mastery, clarification of meaning, emotional bond, agreement on collaboration, 21 items, German version
8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Christina Hunger, Dr., Institute of Medical Psychology, University Hospital Heidelberg/Germany
  • Study Chair: Jochen Schweitzer, Prof. Dr., Institute of Medical Psychology, University Hospital Heidelberg/Germany
  • Study Chair: Hinrich Bents, Dr., Centre for Psychological Psychotherapy Heidelberg (ZPP)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (ACTUAL)

January 1, 2017

Study Completion (ACTUAL)

September 1, 2017

Study Registration Dates

First Submitted

January 21, 2015

First Submitted That Met QC Criteria

February 4, 2015

First Posted (ESTIMATE)

February 10, 2015

Study Record Updates

Last Update Posted (ACTUAL)

October 18, 2019

Last Update Submitted That Met QC Criteria

October 16, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • SOPHO-PT-2014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Anxiety Disorder

Clinical Trials on Systemic Therapy for Social Anxiety Disorder

3
Subscribe